Cerenome is trading at $1.86, up 5.68% in pre-market trading; no confirmed company-specific catalyst was found for the October 29 move. - Cerenome’s latest release said interim clinical data would be presented at the SNO Annual Meeting, November 12–15—not on October 29. - Healthcare was up 1.32% pre-market, a possible sector tailwind that does not establish the cause of Cerenome’s larger move. - Trading volume is unavailable.